ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 156 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $8,418,739 | -23.1% | 393,399 | +45.2% | 0.01% | -28.6% |
Q1 2023 | $10,953,295 | +322720.4% | 270,853 | +271.4% | 0.01% | +180.0% |
Q4 2022 | $3,393 | -99.9% | 72,937 | +34.8% | 0.01% | +25.0% |
Q3 2022 | $2,806,000 | +100.3% | 54,097 | +82.6% | 0.00% | +100.0% |
Q2 2022 | $1,401,000 | – | 29,629 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 1,599,109 | $63,277,000 | 8.68% |
SENZAR ASSET MANAGEMENT, LLC | 566,903 | $22,432,000 | 6.58% |
Sarissa Capital Management LP | 105,000 | $4,155,000 | 1.60% |
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 136,637 | $5,407,000 | 1.41% |
RA Capital Management | 250,000 | $9,893,000 | 1.17% |
BENNETT LAWRENCE MANAGEMENT L L C/NY | 110,515 | $4,373,000 | 0.99% |
Ghost Tree Capital, LLC | 35,000 | $1,385,000 | 0.75% |
WALL STREET ASSOCIATES | 159,100 | $6,296,000 | 0.65% |
BAILARD, INC. | 91,500 | $3,621,000 | 0.56% |
EAM Investors, LLC | 62,768 | $2,484,000 | 0.50% |